Cargando…

Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson’s substantia nigra

Iron deposition in Parkinson’s disease (PD) is a potential disease-modifying target. We previously showed that supplementation of the iron-exporter, ceruloplasmin, selectively corrected nigral iron elevation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model. Ceruloplasmin delivers iro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayton, Scott, Lei, Peng, Mclean, Catriona, Bush, Ashley I, Finkelstein, David I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661661/ https://www.ncbi.nlm.nih.gov/pubmed/29263898 http://dx.doi.org/10.1038/sigtrans.2016.15

Ejemplares similares

Increased Ndfip1 in the Substantia Nigra of Parkinsonian Brains Is Associated with Elevated Iron Levels
por: Howitt, Jason, et al.
Publicado: (2014)

The history of the research of iron in parkinsonian substantia nigra
por: Friedman, Andrzej, et al.
Publicado: (2012)

Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains
por: Gegg, Matthew E, et al.
Publicado: (2012)

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition
por: Croisier, Emilie, et al.
Publicado: (2005)

Brain tissue echogenicity—implications for substantia nigra studies in parkinsonian patients
por: Sadowski, Krzysztof, et al.
Publicado: (2011)

Influence of energy deficiency on the subcellular processes of Substantia Nigra Pars Compacta cell for understanding Parkinsonian neurodegeneration
por: Muddapu, Vignayanandam Ravindernath, et al.
Publicado: (2021)

Biochemical Changes Induced by Embryonic Substantia Nigra Transplanted to the Striatum of Parkinsonian Monkeys
por: Elsworth, J. D., et al.
Publicado: (1992)

Correction: Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition
por: Croisier, Emilie, et al.
Publicado: (2006)

Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson’s disease
por: Ayton, Scott, et al.
Publicado: (2014)

Proteome analysis of human substantia nigra in Parkinson's disease
por: Werner, Cornelius J, et al.
Publicado: (2008)

Proliferation of Inhibitory Input to the Substantia Nigra in Experimental Parkinsonism
por: Faynveitz, Anna, et al.
Publicado: (2019)

Adulthood Exposure to Lipopolysaccharide Exacerbates the Neurotoxic and Inflammatory Effects of Rotenone in the Substantia Nigra
por: Huang, Chun, et al.
Publicado: (2017)

Soemmerring and the Substantia Nigra
por: Faull, R. L. M, et al.
Publicado: (1968)

Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson’s disease
por: Zarbakhsh, Sam, et al.
Publicado: (2019)

Enhanced training protects memory against amnesia produced by concurrent inactivation of amygdala and striatum, amygdala and substantia nigra, or striatum and substantia nigra
por: Salado-Castillo, Rigoberto, et al.
Publicado: (2011)

Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
por: Loeffler, David A, et al.
Publicado: (2006)

Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
por: Dölle, Christian, et al.
Publicado: (2016)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
por: Seyfried, T. N., et al.
Publicado: (2018)

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
por: Trist, Benjamin G., et al.
Publicado: (2019)

Complementary Transcriptomic and Proteomic Analysis in the Substantia Nigra of Parkinson's Disease
por: Dong, Bao-hua, et al.
Publicado: (2021)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
por: Feraco, Paola, et al.
Publicado: (2021)

Ferroptosis-related factors in the substantia nigra are associated with Parkinson’s disease
por: Liu, Lei, et al.
Publicado: (2023)

Classification of Parkinson’s Disease in Patch-Based MRI of Substantia Nigra
por: Hussain, Sayyed Shahid, et al.
Publicado: (2023)

Protocol of a prospective study on the diagnostic value of transcranial duplex scanning of the substantia nigra in patients with parkinsonian symptoms
por: Vlaar, Annemarie MM, et al.
Publicado: (2007)

Baicalin suppresses iron accumulation after substantia nigra injury: relationship between iron concentration and transferrin expression
por: Guo, Chunyan, et al.
Publicado: (2014)

Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson’s Disease and Atypical Parkinsonian Syndromes
por: Fujita, Hiroaki, et al.
Publicado: (2016)

Eyes as Gateways for Environmental Light to the Substantia Nigra: Relevance in Parkinson's Disease
por: Romeo, Stefania, et al.
Publicado: (2014)

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease
por: Reeve, Amy K., et al.
Publicado: (2018)

Corrigendum to: Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease
Publicado: (2020)

Substantia Nigra Integrity Correlates with Sequential Working Memory in Parkinson's Disease
por: Liu, Wenyue, et al.
Publicado: (2021)

Gut microbiota relieves inflammation in the substantia nigra of chronic Parkinson's disease by protecting the function of dopamine neurons
por: Zhang, Tian, et al.
Publicado: (2022)

Repurposing Simvastatin in Parkinson’s Disease Model: Protection Is throughout Modulation of the Neuro-Inflammatory Response in the Substantia nigra
por: Rubio-Osornio, Moisés, et al.
Publicado: (2023)

The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy
por: Zhou, Hai-Yan, et al.
Publicado: (2018)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2020)

Extracellular Nanomatrix‐Induced Self‐Organization of Neural Stem Cells into Miniature Substantia Nigra‐Like Structures with Therapeutic Effects on Parkinsonian Rats
por: Zhang, Shiqing, et al.
Publicado: (2019)

Beneficial effects of PGC-1α in the substantia nigra of a mouse model of MPTP-induced dopaminergic neurotoxicity
por: Wang, Yingqing, et al.
Publicado: (2019)

Isolated substantia nigra involvement in brainstem demyelination
por: Mahale, Rohan R., et al.
Publicado: (2015)

Nicotine impact on rat substantia nigra compacta
por: Elgayar, Sanaa A M, et al.
Publicado: (2021)

Substantia nigra Smad3 signaling deficiency: relevance to aging and Parkinson’s disease and roles of microglia, proinflammatory factors, and MAPK
por: Liu, Ying, et al.
Publicado: (2020)

Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease
por: Flønes, Irene Hana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ck8b804fcsjacku1r2eo6np0d1